Registration for Vision UK 2013 conference now open

Article

Registration for the fifth VISION 2020 UK Annual Vision Strategy is now open.

Registration for the fifth VISION 2020 UK Annual Vision Strategy is now open.

The conference will commence on Tuesday 11 June at the Queen Elizabeth II Conference Centre, London, UK. The main theme will be 'Progress through partnership' and will cover the launch of the refreshed UK Vision Strategy.

A series of workshops will be available for delegates, during which they will have the opportunity to contribute to implementation plans for the new strategy and hear opinions from public health experts in eyecare sectors.

Anna Lightstone, Programme Director, UK Vision Strategy and Interim Chief Operations, commented, "It is an exciting time as we launch the refreshed UK Vision Strategy and the conference will provide an excellent opportunity for those in the eye health, public health and sight loss sectors to plan how to successfully implement this over the next five years."

For those interested in sponsorship and exhibitor opportunities please ukvisionstrategy@rnib.org.uk the UK Vision Strategy team.

Please click here to book your place at the VISION 2020 2013 conference.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.